Temporal Dynamics of a Predominant Protease Inhibitor–Resistance Mutation in a Treatment-Naive, Hepatitis C Virus–Infected Individual (Q27488198)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive, hepatitis C virus-infected individual (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Arthur Y Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Joerg Timm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Brian E Nolan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Laura L Reyor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Katherine Kane

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Andrew C Berical

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Kimon C Zachary

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Thomas Kuntzen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Todd M Allen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

Journal of Infectious Diseases

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

737-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

21 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Relative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon System

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Viral Sequence Evolution in Acute Hepatitis C Virus Infection

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants: sensitivity to telaprevir (VX-950) and interferon alpha

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

The HBV drug entecavir - effects on HIV-1 replication and resistance

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Treating viral hepatitis C: efficacy, side effects, and complications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naïve chronically infected patient

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653266

27 November 2018

Identifiers

DOI

10.1086/596657

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

PubMed publication ID

19199553

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19199553%20AND%20SRC:MED&resulttype=core&format=json